Jun Liang

机构：Fudan University, Huashan Hospital · ORCID：0000-0002-6833-0749

发表论文 62 篇 · 总被引 1816 次 · h-index 21

代表论文

• GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer (2021 · Journal of Medicinal Chemistry · 被引 139)
• Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A Mendelian randomization (2023 · Frontiers in Immunology · 被引 116)
• Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbA (2018 · Antimicrobial Agents and Chemotherapy · 被引 76)
• Monomeric Targeted Protein Degraders (2020 · Journal of Medicinal Chemistry · 被引 64)
• Tacrolimus nanocrystals microneedle patch for plaque psoriasis (2022 · International Journal of Pharmaceutics · 被引 50)
• Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER+ Breast Cancer (2020 · ACS Medicinal Chemistry Letters · 被引 31)